Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic *** > Treatment > CH. N. OfatumuMAb ***
CH. N. OfatumuMAb ***'s subsections
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 10.09.
TradeMark
TradeMark Web-Site (USA)
CH. N. OfatumuMAb ***'s products
This section has no products